Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NVO

Novo Nordisk ADR

Feb 06 • 04:00PM ET

47.64

+4.30 9.92 %

Healthcare • Drug Manufacturers - General • Denmark • NYSE

Peers: LLY MRK ABBV JNJ AMGN AZN-D PFE SNY BMY GSK

| Held by: PVAL PPH AVDE FTHI PID WCMI PINK OZEM AQEC APIE

Scroll to Statements

Index	-	P/E	13.74	EPS (ttm)	3.47	Insider Own	0.00%	Shs Outstand	3.37B	Perf Week	-19.84%
Market Cap	160.51B	Forward P/E	13.59	EPS next Y	3.51	Insider Trans	-	Shs Float	3.37B	Perf Month	-15.79%
Enterprise Value	176.86B	PEG	6.09	EPS next Q	0.82	Inst Own	9.02%	Short Float	0.84%	Perf Quarter	-1.69%
Income	15.45B	P/S	3.43	EPS this Y	-7.05%	Inst Trans	-1.57%	Short Ratio	1.28	Perf Half Y	-2.30%
Sales	46.77B	P/B	6.94	EPS next Y	3.65%	ROA	20.59%	Short Interest	28.16M	Perf YTD	-6.37%
Book/sh	6.87	P/C	37.86	EPS next 5Y	2.23%	ROE	61.25%	52W High	93.80 -49.21%	Perf Year	-44.43%
Cash/sh	1.26	P/FCF	17.93	EPS past 3/5Y	26.28% 20.36%	ROIC	31.38%	52W Low	43.08 10.58%	Perf 3Y	-31.49%
Dividend Est.	1.68 (3.53%)	EV/EBITDA	7.82	Sales past 3/5Y	23.19% 19.21%	Gross Margin	80.90%	Volatility	7.08% 3.79%	Perf 5Y	35.32%
Dividend TTM	1.73 (3.63%)	EV/Sales	3.78	EPS Y/Y TTM	5.57%	Oper. Margin	41.17%	ATR (14)	2.84	Perf 10Y	70.54%
Dividend Ex-Date	Mar 30, 2026	Quick Ratio	0.57	Sales Y/Y TTM	11.11%	Profit Margin	33.03%	RSI (14)	37.00	Recom	2.26
Dividend Gr. 3/5Y	38.95% 26.58%	Current Ratio	0.80	EPS Q/Q	3.95%	SMA20	-17.47%	Beta	0.74	Target Price	59.08
Payout	48.38%	Debt/Eq	0.67	Sales Q/Q	0.66%	SMA50	-10.46%	Rel Volume	1.63	Prev Close	43.34
Employees	68794	LT Debt/Eq	0.61	Earnings	Feb 04 BMO	SMA200	-18.68%	Avg Volume	22.04M	Price	47.64
IPO	Apr 30, 1981	Option/Short	Yes / Yes	EPS/Sales Surpr.	3.40% 3.10%	Trades		Volume	35,886,549	Change	9.92%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-27-26	Initiated	Citigroup	Neutral
Dec-08-25	Downgrade	Argus	Buy → Hold
Oct-27-25	Resumed	Jefferies	Underperform
Oct-01-25	Upgrade	HSBC Securities	Hold → Buy
Sep-29-25	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$47
Sep-17-25	Upgrade	Berenberg	Hold → Buy
Sep-16-25	Upgrade	Rothschild & Co Redburn	Neutral → Buy
Sep-09-25	Upgrade	Bernstein	Mkt Perform → Outperform
Aug-13-25	Upgrade	BNP Paribas Exane	Underperform → Neutral	$54
Aug-05-25	Downgrade	UBS	Buy → Neutral
Jul-31-25	Downgrade	HSBC Securities	Buy → Hold	$57
Jul-30-25	Downgrade	Barclays	Overweight → Equal Weight
Apr-17-25	Downgrade	BMO Capital Markets	Outperform → Market Perform	$64
Mar-13-25	Upgrade	Kepler	Hold → Buy
Mar-03-25	Downgrade	Stifel	Buy → Hold
Feb-12-25	Initiated	Morgan Stanley	Equal-Weight
Jan-06-25	Upgrade	Bernstein	Underperform → Mkt Perform
May-30-24	Initiated	Goldman	Buy	$156
Apr-12-24	Initiated	BMO Capital Markets	Outperform	$163
Jan-23-24	Initiated	Morgan Stanley	Overweight	$120

Show Previous Ratings

Today 12:56AM	Jim Cramer on Novo Nordisk: "It Seems Eli Lilly's Eating Their Lunch" (Insider Monkey)
Feb-06-26 10:08PM	Novo Nordisk A/S Q4 Earnings Call Highlights (MarketBeat) +9.92%
05:45PM	FDA scrutiny rattles Hims & Hers stock (Investing.com)
05:45PM	Eli Lilly Booms, Then Busts: Stellar Guidance vs Hims Undercut (MarketBeat)
05:13PM	TrumpRx Is Here. Most People Wont Benefit. (Barrons.com)
04:13PM	Loading…
04:13PM	Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers (Barrons.com)
03:29PM	Hims & Hers stock nears one-year low amid battle over compounded Wegovy pill (MarketWatch)
01:51PM	What's Going On With Novo Nordisk Stock On Friday? (Benzinga)
12:53PM	Big-Name Earnings, Selloffs Highlight Busy Week on Wall Street (Schaeffer's Research)
12:38PM	These Stocks Are Todays Movers: Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More (Barrons.com)
11:58AM	TrumpRx launches to slash drug prices for cash-paying US patients (Pharmaceutical Technology)
11:52AM	Hims & Hers Stock Drops. It May Be Losing Its Weight-Loss Battle With Novo. (Barrons.com)
11:06AM	Pfizer Bets Big on Obesity and Oncology With 2026 Pipeline Push (Zacks)
10:41AM	Novo Nordisk Shares Slide 21% After Forecast Cut, Copycat Wegovy Pill Launch (GuruFocus.com)
10:37AM	Hims & Hers falls ~8% premarket after FDA warning on copycat drugs (GuruFocus.com)
09:27AM	Loading…
09:27AM	NVO, LLY Stocks Slide as HIMS Launches $49 Compounded Semaglutide Pill (Zacks)
08:22AM	Hims & Hers stock falls after FDA warns against illegal copycat drugs (Investing.com)
07:52AM	Novos Stratospheric Rise Has Turned Into a $460 Billion Wipeout (Bloomberg)
07:36AM	Novo Nordisk Rebounds After FDA Signals Crackdown on Copycat Drugs (GuruFocus.com)
07:22AM	FDA targets illegal drug copies amid latest Hims & Hers/Novo Nordisk flashpoint (Pharmaceutical Technology)
07:17AM	Citi flags lingering risks to Novo despite strong weight-loss portfolio (Proactive)
07:04AM	Novo Stock Jumps, Hims & Hers Tanks. This Could Shift the Weight-Loss Copycat Battle. (Barrons.com)
07:02AM	Novo Nordisk Shares Rebound as FDA Moves Against Illegal Drug Copies (GuruFocus.com)
06:05AM	These Stocks Are Today's Movers: Amazon, Strategy, Novo Nordisk, Molina Healthcare, Strategy, Roblox, Hub Group, and More (Barrons.com)
04:51AM	Novo shares rebound as FDA vows crackdown on weight-loss drug copies (Investing.com)
04:25AM	Novo Nordisk stock climbs out of hole on FDA chief's threat to block Hims and Hers pill (MarketWatch)
12:13AM	Trump Says People Will 'Save A Lot Of Money And Be Healthy' With Launch Of TrumpRx Website - But Will It Actually Fill Prescriptions? (Benzinga)
Feb-05-26 08:24PM	White House Debuts Drug-Buying Site TrumpRx, With Roughly 40 Medications (The Wall Street Journal) -8.16%
07:52PM	Hims Launches Oral Wegovy Knockoff, But The FDA Could Prove To Be A Problem (Investor's Business Daily)
04:53PM	These Stocks Are Todays Movers: Alphabet, Qualcomm, Broadcom, AMD, Strategy, Novo Nordisk, Amazon, and More (Barrons.com)
04:31PM	Loading…
04:31PM	Hims Is Already Knocking Off Novo's Wegovy Pill For Just $49 A Month (Investor's Business Daily)
04:17PM	TrumpRx's launch is hours away. Here's why it may not lower drug prices for most Americans. (MarketWatch)
04:11PM	Hims & Hers Launches New Pill That Sends Shockwaves Across Weight-Loss Drugmakers' Stocks (Investopedia)
04:08PM	Hims offers cheapest GLP-1 weight-loss pill in US in a shock to Novo, Lilly (Reuters)
03:40PM	Analyst Report: Novo Nordisk A/S (Morningstar Research)
02:35PM	Nasdaq drags major indexes lower as Alphabet spending plans spook investors (Proactive)
02:11PM	Dow falls sharply, Hims' Wegovy rival, Nio's profit outlook (Yahoo Finance Video)
02:05PM	Hims & Hers Is Introducing a Cheaper Wegovy Copycat. Novo Nordisk Stock Falls. (Barrons.com)
01:30PM	Hims & Hers launches copy of Wegovy pill, prompting legal threats from drugmaker Novo Nordisk (Associated Press Finance)
01:22PM	Novo Nordisk vows legal action to protect Wegovy pill (AFP)
01:15PM	Hims & Hers offers cheaper weight-loss pill in a shock to Novo (Reuters Videos)
01:13PM	Novo Nordisk Threatens Legal Action Over Hims & Hers' Wegovy Alternative (GuruFocus.com)
12:53PM	Novo Nordisk Accuses Hims & Hers of Illegal Mass Compounding Over Cheaper Wegovy Version (The Wall Street Journal)
12:51PM	Hims & Hers Launches Compounded Version Of Wegovy, Novo Nordisk Threatens Legal Action (Benzinga)
12:08PM	Hims & Hers launches compounded semaglutide pill as lower-cost weight loss option (Proactive)
10:56AM	Hims & Hers launch of compounded $49 Wegovy pill pummels Novo Nordisk's shares (MarketWatch)
09:36AM	Hims stock surges as Wegovy pill copy offered at $49, Novo shares fall (Investing.com)
09:34AM	The Metabolic Split: Why Eli Lilly Soars as Novo Stumbles (MarketBeat)
03:00AM	The most valuable up-and-coming GLP-1s (Pharma Voice)
03:00AM	Big Pharmas most valuable up-and-coming GLP-1s (Pharma Voice)
Feb-04-26 06:44PM	Analyst Report: Novo Nordisk A/S (Morningstar Research) -6.18%
06:44PM	Patient preference is leaning towards Eli Lilly's weight loss drugs, says Guggenheim's Fernandez (CNBC TV)
04:21PM	Eli Lilly Stock Soars While Novo Nordisk SinksWhy the Weight-Loss Leaders Are Headed in Opposite Directions (Investopedia)
04:08PM	Eli Lilly Surges On 'Assertive' Guidance That Assuages Novo Nordisk-Tied Worries (Investor's Business Daily)
04:07PM	Novo Continues Two-Day Plunge As CFO Acknowledges 'Extraordinary' Challenges In 2026 (Investor's Business Daily)
04:07PM	Eli Lilly Again Tops $1 Trillion Market Cap. Earnings Show the Stock Can Still Surprise. (Barrons.com)
04:00PM	Stock market today: S&P 500, Nasdaq fall for 2nd day as tech slides on AI worries with Google earnings ahead (Yahoo Finance)
03:48PM	Stock market today: S&P 500, Nasdaq sink as AI worries fuel return to tech sell-off ahead of Google earnings (Yahoo Finance)
03:15PM	Novo Nordisk Plunges After Releasing a Brutal Forecast. Should You Dump the Stock? (Motley Fool)
02:39PM	Eli Lilly Is Dominating the GLP-1 Wars as Novo Nordisk Sales Tank (24/7 Wall St.)
02:11PM	Eli Lilly stock surges after company touts strong sales outlook as rival Novo Nordisk continues plunge (Yahoo Finance)
02:02PM	In Weight Loss Drug Battle For 2026, Eli Lilly Pulls Ahead Of Novo Nordisk (Benzinga)
02:01PM	Novo Nordisk AS (NVO) Q4 2025 Earnings Call Highlights: Record Obesity Care Sales and Strategic ... (GuruFocus.com)
01:51PM	Novo Nordisk Proposes DKK 7.95 Dividend; DKK 15B Buyback (GuruFocus.com)
12:29PM	Health Care Roundup: Market Talk (The Wall Street Journal)
12:20PM	Novo Nordisk Stock Extends Losses as Ozempic Maker Sees Sales Falling in 2026 (Barrons.com)
12:10PM	Eli Lilly Guides Up to 27% Sales Growth as Obesity Demand Surges (GuruFocus.com)
12:02PM	Emcure Pharmaceuticals Ltd (BOM:544210) Q3 2026 Earnings Call Highlights: Strong Revenue Growth ... (GuruFocus.com)
11:40AM	Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026 (Motley Fool)
11:07AM	Stock market today: Dow jumps, S&P 500, Nasdaq fall with AI worries in focus ahead of Google earnings (Yahoo Finance)
11:06AM	Eli Lilly, Novo Nordisk, AbbVie: Pharma earnings roundup (Yahoo Finance Video)
10:55AM	Novo Nordisk Stock Sinks on Weak Sales Forecast (Schaeffer's Research)
10:22AM	Lilly Stock Jumps After Q4 Earnings Beat and Strong 2026 Guidance (Zacks)
10:19AM	AMGN's Q4 Earnings & Sales Beat Estimates, Obesity Candidate in Focus (Zacks)
09:38AM	Eli Lilly vs. Novo Nordisk: Fortunes Diverge for the Weight-Loss Drug Titans (The Wall Street Journal)
09:31AM	Stock Market News for Feb 4, 2026 (Zacks)
09:30AM	Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales Outlook (Zacks)
09:28AM	Sales warning slams Ozempic maker Novo Nordisk's stock (AFP)
09:16AM	NVO Q4 Earnings & Sales Beat Estimates, Stock Down on Poor 2026 View (Zacks)
09:01AM	The weight loss drug giants are going in opposite directions (Quartz)
08:58AM	PepsiCo CEO sees big opportunities from GLP-1 drugs (Just Food)
08:48AM	Novo Nordisk A/S Q4 Earnings Call Highlights (MarketBeat)
08:47AM	Eli Lilly leaves Novo Nordisk in the dust in weight loss drug race (Quartz)
08:39AM	Mounjaro Maker Eli Lilly Banks On Bigger 2026 Thanks To Weight Loss Drugs (Benzinga)
08:36AM	Eli Lilly Earnings Show the Stock Can Still Surprise (Barrons.com)
08:30AM	Novo Nordisk shares plummet as gloomy outlook shocks markets (Reuters Videos)
07:54AM	Novo Nordisk Warns Sales Could Fall Up to 13%, Shares Drop 20% (GuruFocus.com)
07:45AM	Novo Nordisk shares tumble 18% after 2026 sales dip warning (Pharmaceutical Technology)
07:44AM	$285 Billion AI-Led Selloff Triggers Rotation Into Small Caps (GuruFocus.com)
07:25AM	Novo Shares Plunge on Shock Weight-Loss Drug Forecast (Bloomberg)
07:23AM	Shares dip as Anthropic update hits software stocks; gold glitters (Reuters Videos)
07:21AM	Lilly says Mounjaro and Zepbound sales grew by at least 110% as stock rallies (MarketWatch)
06:56AM	Eli Lilly Stock Jumps on Strong Earnings. Weight-Loss Drugs Have Something to Do With It. (Barrons.com)
06:54AM	Eli Lilly sees 2026 profit above estimates as demand for weightloss drugs soars (Reuters)
06:52AM	Ozempic Maker Novo Nordisk Flags Declining Sales In 2026 (Benzinga)
06:42AM	Novo Nordisk stock sinks by 17% after bleak 2026 forecast (Euronews)
06:38AM	Stocks fluctuate after Wall St AI-fuelled sell-off (AFP)
06:12AM	Novo Nordisk Faces Massive Sell-Off After Weak 2026 Outlook (GuruFocus.com)
05:41AM	These Stocks Are Today's Movers: AMD, Super Micro, Enphase, Alphabet, Chipotle, Silicon Labs, Take-Two, Novo Nordisk, and More (Barrons.com)
05:26AM	Here's the Incredible Rise and Fall of Novo Nordisk's Stock (The Wall Street Journal)

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Novo Nordisk A/S	10% Owner	May 30 '25	Proposed Sale	2.14	921,897	1,972,859		May 30 08:31 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVO

Novo Nordisk ADR

Upgrade your FINVIZ experience